13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001773206
Total reported value
$2.5B
$2.5B
80 檔
11.9%
During the Q1 2025 filing period, Integral Health Asset Management, LLC (CIK: 0001773206) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $2.5B across 80 reported positions.
Integral Health Asset Management, LLC executed strategic sector rebalancing during Q1 2025, establishing 68 new positions while fully exiting 59 holdings and trimming 3 positions.
In terms of portfolio concentration, the top 5 core holdings (including INSM, BSX, CYTK) accounted for 11.9% of total reported equity market value during Q1 2025.
Top New Position Initiated
INSM
市值: $118.2M
Top Position Liquidated / Trimmed
ARNAEUR
前期市值: $15.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | Stock-Healthcare | 12.58% | -4.99% | -24.39% | |
| 2 | BSX | Boston Scientific CORP | Stock-Healthcare | 6.98% | -0.13% | +18.18% | |
| 3 | CYTK | Cytokinetics Inc | Stock-Healthcare | 4.70% | -2.82% | +10.00% | |
| 4 | THC | Tenet Healthcare CORP | Stock-Healthcare | 3.94% | +1.22% | NEW | |
| 5 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 3.89% | -1.14% | +162.86% | |
| 6 | ELV | Elevance Health Inc | Stock-Healthcare | 3.01% | -0.29% | — | |
| 7 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 2.97% | -0.59% | — | |
| 8 | VERA | Vera Therapeutics Inc | Stock-Other | 2.94% | -0.11% | — | |
| 9 | EHC | Encompass Health CORP | Stock-Healthcare | 2.91% | — | -10.00% | |
| 10 | MDT | Medtronic plc | Stock-Healthcare | 2.87% | +0.62% | NEW | |
| 11 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 2.28% | +0.80% | +14.71% | |
| 12 | GILD | Gilead Sciences Inc | Stock-Healthcare | 2.09% | -0.67% | EXIT | |
| 13 | BAX | Baxter International Inc | Stock-Healthcare | 1.82% | — | — | |
| 14 | FMS | Fresenius Medical Care-adr | Stock-Other | 1.80% | -0.84% | EXIT | |
| 15 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 1.77% | +0.05% | -6.25% | |
| 16 | ASND | Ascendis Pharma A/S | Stock-Other | 1.66% | -1.26% | EXIT | |
| 17 | BTSG | Brightspring Health Services | Stock-Other | 1.49% | -1.03% | -18.42% | |
| 18 | CVS | Cvs Health CORP | Stock-Healthcare | 1.44% | +3.97% | -60.00% | |
| 19 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.44% | — | +11.11% | |
| 20 | QURE | uniQure N.V. | Stock-Other | 1.41% | +0.94% | +13.64% | |
| 21 | ACLXGBX | Arcellx Inc | Stock-Other | 1.40% | — | +100.00% | |
| 22 | 2655787D | Blueprint Medicines CORP | Stock-Other | 1.37% | — | -47.27% | |
| 23 | ABBV | Abbvie Inc | Stock-Healthcare | 1.34% | — | — | |
| 24 | RDNT | Radnet Inc | Stock-Healthcare | 1.32% | — | — | |
| 25 | GEHC | GE Healthcare Technology | Stock-Healthcare | 1.29% | +0.38% | NEW | |
| 26 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 1.15% | — | +9.09% | |
| 27 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 1.10% | +0.18% | NEW | |
| 28 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 1.09% | -0.67% | EXIT | |
| 29 | PEN | Penumbra Inc | Stock-Healthcare | 1.00% | — | — | |
| 30 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.96% | +1.58% | — | |
| 31 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 0.94% | +0.53% | -54.55% | |
| 32 | MCK | Mckesson CORP | Stock-Healthcare | 0.86% | — | -65.71% | |
| 33 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 0.83% | — | — | |
| 34 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 0.82% | — | — | |
| 35 | ETNBGBP | 89bio Inc | Stock-Other | 0.81% | — | +5.00% | |
| 36 | PFE | Pfizer Inc | Stock-Healthcare | 0.81% | — | — | |
| 37 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 0.81% | +0.25% | -16.67% | |
| 38 | MASI* | Masimo CORP | Stock-Other | 0.80% | — | — | |
| 39 | WAT | Waters CORP | Stock-Healthcare | 0.78% | +0.59% | NEW | |
| 40 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 0.78% | — | — | |
| 41 | DXCM | Dexcom Inc | Stock-Healthcare | 0.73% | -0.53% | EXIT | |
| 42 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.71% | -0.08% | — | |
| 43 | RGNX | Regenxbio Inc | Stock-Other | 0.70% | -0.22% | +2.78% | |
| 44 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.65% | — | -71.43% | |
| 45 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 0.64% | +0.15% | — | |
| 46 | TARA | Protara Therapeutic Inc | Stock-Other | 0.63% | -0.21% | — | |
| 47 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 0.63% | — | — | |
| 48 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 0.56% | -0.29% | EXIT | |
| 49 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.54% | — | — | |
| 50 | PTCT | Ptc Therapeutics Inc | Stock-Healthcare | 0.54% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CYTK | Cytokinetics Inc | +0.9% | +10.00% | Add |
| 2 | ALNY | Alnylam Pharmaceuticals Inc | +0.3% | +11.11% | Add |
| 3 | MDT | Medtronic plc | +0.1% | +100.00% | Add |
| 4 | ALKS | Alkermes plc | -0.5% | — | Unchanged |
| 5 | BNTX | Biontech Se-adr | -0.7% | -60.00% | Add |
| 6 | PTCT | Ptc Therapeutics Inc | -0.7% | — | Trim |
| 7 | EW | Edwards Lifesciences CORP | -0.9% | — | Add |
| 8 | 2655787D | Blueprint Medicines CORP | -1.1% | -47.27% | Add |
| 9 | FATE | Fate Therapeutics Inc | -1.9% | +16.67% | Add |
| 10 | ELV | Elevance Health Inc | -2.3% | — | Add |
| 11 | GMED | Globus Medical Inc - A | -2.4% | — | Trim |
| 12 | ACHC | Acadia Healthcare Co Inc | -3.7% | -16.67% | Trim |
| 13 | INSM | Insmed Inc | — | NEW | New buy |
| 14 | BSX | Boston Scientific CORP | — | NEW | New buy |
| 15 | THC | Tenet Healthcare CORP | — | NEW | New buy |
| 16 | MLYS | Mineralys Therapeutics Inc | — | NEW | New buy |
| 17 | NVS | Novartis Ag-sponsored Adr | — | NEW | New buy |
| 18 | VERA | Vera Therapeutics Inc | — | NEW | New buy |
| 19 | EHC | Encompass Health CORP | — | NEW | New buy |
| 20 | EWTX | Edgewise Therapeutics Inc | — | NEW | New buy |
| 21 | GILD | Gilead Sciences Inc | — | NEW | New buy |
| 22 | BAX | Baxter International Inc | — | NEW | New buy |
| 23 | FMS | Fresenius Medical Care-adr | — | NEW | New buy |
| 24 | NBIX | Neurocrine Biosciences Inc | — | NEW | New buy |
| 25 | ASND | Ascendis Pharma A/S | — | NEW | New buy |
| 26 | ARNAEUR | Arena Pharmaceuticals Inc | — | EXIT | Sold out |
| 27 | BTSG | Brightspring Health Services | — | NEW | New buy |
| 28 | CVS | Cvs Health CORP | — | NEW | New buy |
| 29 | QURE | uniQure N.V. | — | NEW | New buy |
| 30 | ACLXGBX | Arcellx Inc | — | NEW | New buy |
| 31 | SG7 | Sage Therapeutics Inc | — | EXIT | Sold out |
| 32 | ABBV | Abbvie Inc | — | NEW | New buy |
| 33 | RDNT | Radnet Inc | — | NEW | New buy |
| 34 | BIIB | Biogen Inc | — | EXIT | Sold out |
| 35 | GEHC | GE Healthcare Technology | — | NEW | New buy |
| 36 | KRYS | Krystal Biotech Inc | — | NEW | New buy |
| 37 | INSP | Inspire Medical Systems Inc | — | NEW | New buy |
| 38 | REGN | Regeneron Pharmaceuticals | — | EXIT | Sold out |
| 39 | TARS | Tarsus Pharmaceuticals Inc | — | NEW | New buy |
| 40 | UHS | Universal Health Services-b | — | EXIT | Sold out |
| 41 | PEN | Penumbra Inc | — | NEW | New buy |
| 42 | SNY | Sanofi-adr | — | EXIT | Sold out |
| 43 | RVMD | Revolution Medicines Inc | — | NEW | New buy |
| 44 | LHCGUSD | Lhc Group Inc | — | EXIT | Sold out |
| 45 | MRTXEUR | Mirati Therapeutics Inc | — | EXIT | Sold out |
| 46 | MCK | Mckesson CORP | — | NEW | New buy |
| 47 | TFX | Teleflex Inc | — | EXIT | Sold out |
| 48 | COR | Cencora Inc | — | EXIT | Sold out |
| 49 | MLTX | Moonlake Immunotherapeutics | — | NEW | New buy |
| 50 | NVST | Envista Holdings CORP | — | EXIT | Sold out |
According to official SEC Form 13F filings, Integral Health Asset Management, LLC reported a total U.S. public equity portfolio value of $2.5B across 80 disclosed positions in Q1 2025.
During Q1 2025, Integral Health Asset Management, LLC's top holdings by market value included INSM (12.6%)、BSX (7.0%)、CYTK (4.7%). The largest single position, INSM, represented 12.6% of total portfolio value.
In Q1 2025, Integral Health Asset Management, LLC made 138 total portfolio adjustments, initiating 68 new buys, adding to 8 positions, trimming 3 holdings, and fully liquidating 59 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.